ENTITY
Jenscare Scientific

Jenscare Scientific (9877 HK)

34
Analysis
Health CareHong Kong
Jenscare Scientific Co., Ltd. manufactures and distributes medical devices. The Company produces transcatheter tricuspid valve replacement systems and others. Jenscare Scientific offers treatment solutions targeting different types of structural heart diseases, including tricuspid valve diseases, aortic valve diseases, mitral valve diseases, heart failure, and others.
more
Refresh
01 Feb 2022 09:13

Pre-IPO Shanghai NewMed Medical - Concerns on Fierce Competition and Future Commercialization

We analyzed the industry characteristics of heart valve device market. Concerns of NewMed are mainly the slow product development progress, fierce...

Logo
297 Views
Share
29 Aug 2021 09:38

ECM Weekly (29th August 2021) - Imeik, Helen’s, Jenscare, Dingdang, Simplex, Hyundai Heavy

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
26 Aug 2021 14:25

Jenscare (宁波健世科技) Pre-IPO: Differentiated Heart Valve Portfolio

Jenscare has a differentiated heart valve portfolio with leadership in the tricuspid heart valve replacement segment. We think the company is...

Logo
284 Views
Share
03 Aug 2021 09:12

Pre-IPO Jenscare Scientific - The Industry Characteristics, the Business and the Challenges

The article mainly analyzed Jenscare in terms of the industry characteristics of China interventional therapies of structural heart disease,the...

Logo
197 Views
Share
x